常规的无细胞DNA产前查可以识别患有囊性纤维化高风险的怀孕,这些怀孕可能受益于胎儿治疗
J Wynn1, S Rego1, D Chandler-Brown1
1BillionToOne Inc., Menlo Park, CA, USA.
概括
使用无细胞DNA准确查胎儿囊性纤维化 (CF) 的非侵入性产前检测在头三个月. 这种方法提供了早期的,个性化的风险评估,不需要合作伙伴样本,指导及时干预.
科学领域:
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
- 产前诊断 在产前诊断
背景情况:
- 无细胞DNA (cfDNA) 技术的进步使得胎儿单基因自体衰退条件的非侵入性产前检测 (NIPT) 成为可能.
- 现在,NIPT可以在怀孕第一季度从母亲的血液中查胎儿囊性纤维化 (CF) 风险.
- 这种方法消除了对伴侣样本的需求,与传统的载体查不同.
研究的目的:
- 评估基于cfDNA的NIPT在一般风险孕妇群体中用于胎儿CF查的性能.
- 评估cfDNA测试的准确性和效率,以识别患CF高风险的胎儿.
- 确定cfDNA测试的周转时间及其对早期干预的影响.
主要方法:
- 100,106名一般风险孕妇接受CF携带者查的回顾性审查.
- 在阳性CF载体上进行的无细胞DNA测试,将≥1/4风险的怀孕归类为高风险.
- 从高风险病例中征集确认性测试结果;从低风险病例的随机样本中计算的绩效分析.
主要成果:
- 该研究包括2587名CF携带者和20例具有高风险cfDNA结果的病例;13名胎儿被证实受到影响.
- 该cfDNA测定显示了100%的灵敏度,正确地确定所有已知的受影响胎儿都是高风险的.
- 75%的cfDNA胎儿风险结果可在妊娠18.5周之前获得,允许及时进行诊断测试和潜在的子宫内治疗.
结论:
- 使用反射cfDNA分析进行载体查,可提供个性化的胎儿CF风险评估,并提供高效的周转时间.
- 这种方法可以进行早期妊娠年龄查,而不需要对一般风险人群进行伴侣样本.
- 查方法精确指导CF受影响胎儿的产前诊断测试,可能从子宫内治疗中受益.
相关概念视频
Cystic Fibrosis: Pathogenesis
730
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
730
Cystic Fibrosis: Management
477
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
477


